维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="LATHIA C"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Pharmacokinetic results of aphase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors 显示文摘	Brendel E Ludwig M Lathia C	2011	Cancer Chemother Pharmacol2011，68，：	1
2	Biomarkers predic-ting outcome in patients with advanced renal cell carci-noma: Results from sorafenib phase 111 Treatment Ap-proaches in Renal Cancer Global Evaluation Trial 显示文摘	Pena C Lathia C Shan M	2010	Clin Cancer Res2010，16，19：	1
3	Inflammation stimulates myelina--tion by transplanted oligodendroeyte precursor cels显示文摘	Setzu A Lathia JD Zhao C	2006	Glia2006，54，4：	1
4	Interaction of sorafenib andcytochrome P450 isoenzymes in patients with advanced melanoma : aphase I/II pharmacokinetic interaction study显示文摘	Flaherty KT Lathia C Frye RF	2011	Cancer ChemotherPharmacol2011，68，：	1
5	Lack of effect of ketoconazole -mediated CYP3A inhibition on sorafenib clinical pharmacokinetics 显示文摘	Lathia C Lettieri J Cihon F	2006	Cancer Chemother Pharmacol2006，57，：	1
6	Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors 显示文摘	BRENDEL E LUDWIG M LATHIA C	2011	Cancer Chemother Pharmacol2011，68，1：	1
7	Interaction ofsorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study 显示文摘	FLAHERTY K T LATHIA C FRYE R F	2011	Cancer Chemother Pharmacol2011，68，5：	1
8	Chemokine receptor CX- CR4 signaling modulates the growth factor-induced cell cycle of self-renewing and multipotent neural progenitor cells显示文摘	Li M Chang C J Lathia JD	2011	Glia2011，59，1：	1
9	Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics 显示文摘	Lathia C Lettieri J Cihon F	2006	Cancer Chemother Pharmacol2006，57，：	1
10	Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells显示文摘	Setzu A Lathia JD Zhao C	2006	Glia2006，54，4：	1
11	Plasma biomark- ers as predictors of outcome in patients with advanced hepatocellular carcinoma显示文摘	Llovet J M Pefia C E Lathia C D	2012	Clin Cancer Res2012，18，：	1
12	Interaetion of sorafenib and eytoehrome P450 isoenzymes in patients with advanced melanoma: a phase I/If phannaeokinetie interaction study 显示文摘	Flaherty KT Lathia C Frye RF	2011	Cancer Chemother Phannaeol2011，68，5：	1
13	Lack of effect ofketo- conazole-mediated CYP3A inhibition on sorafenib clini- cal pharmacokinetics显示文摘	Lathia C Lettieri J Cihon F	2006	Cancer Chemother Pharmacol2006，57，5：	1
14	Lack of effect of keto- conazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics 显示文摘	Lathia C Lettieri J Cihon F	2006	Cancer Chemother Pharmacol2006，57，：	1
15	Lack of effect of keto- conazole mediated CYP3A inhibition on sorafenib clinical pharmacokinetics 显示文摘	Lathia C Lettiefi J Cihou F	2006	Cancer Chemother Phamacol2006，57，5：	1
16	Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics显示文摘	LATHIA C LETTIERI J CIHON F	2006	Cancer Chemother Pharmacol2006，57，5：	1
17	Pharmacokinetic results of aphase I trial of sorafenib in combination with dacarbazine in patientswith advanced solid tumors 显示文摘	Brendel E Ludwig M Lathia C	2011	Cancer Chemother Pharmacol2011，68，：	1
18	Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase Ⅰ / Ⅱ pharmacokinetic in- teraction study显示文摘	Flaherty KT Lathia C Frye RF	2011	Cancer Chemother Pharmacol2011，68，12：	1
19	Interaction of sorafenib andcytochrome P450 isoenzymes in patients with advanced melanoma : aphase I/II pharmacokinetic interaction study显示文摘	Flaherty KT Lathia C Frye RF	2011	Cancer ChemotherPharmacol2011，68，：	1
20	Pharmacokinetic results of a phase Ⅰ trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors显示文摘	Brendel E Ludwig M Lathia C	2011	Cancer Chemother Pharmacol2011，68，1：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示